av/vycor-medical--big.svg

COM:VYCORMEDICAL

Vycor Medical

  • Stock

Market Cap

2.93M

Beta: -

Volume Today

10K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
248.72K
-
271.47K
9.15%
314.28K
15.77%
248.30K
20.99%
208.98K
15.84%
208.50K
0.23%
206.82K
0.80%
195.81K
5.32%
194.31K
0.77%
228.20K
17.44%
241.51K
5.83%
average payables
220.91K
-
237.86K
7.68%
236.03K
0.77%
250.16K
5.98%
195.63K
21.80%
117.14K
40.12%
172.44K
47.21%
215.52K
24.98%
203.41K
5.62%
213.88K
5.15%
158.92K
25.70%
average receivables
178.50K
-
168.24K
5.75%
115.08K
31.60%
127.56K
10.85%
129.60K
1.60%
183.94K
41.93%
267.74K
45.56%
218.63K
18.34%
142.67K
34.74%
141.15K
1.06%
185.72K
31.57%
book value per share
-0.52
-
0.28
153.66%
0.11
62.42%
-0.00
102.26%
0.00
285.54%
-0.04
903.03%
-0.06
58.82%
-0.08
34.28%
-0.08
6.50%
-0.09
14.72%
-0.10
9.97%
capex per share
-0.03
-
-0.02
45.90%
-0.03
62.95%
-0.01
80.88%
-0.01
92.12%
-0.00
70.51%
-0.00
17.33%
-0.00
2.22%
-0.00
45.52%
-0.00
93.23%
-0.00
228.35%
capex to depreciation
-0.52
-
-0.45
13.71%
-0.80
78.51%
-0.21
73.07%
-0.63
194.25%
-0.36
43.32%
-0.84
134.22%
-1.07
27.76%
-0.56
47.67%
-0.05
91.93%
-0.15
241.24%
capex to operating cash flow
0.27
-
0.06
76.25%
0.25
297.81%
0.12
54.14%
0.35
200.52%
0.24
29.77%
-8.07
3,405.98%
0.25
103.09%
-1.80
820.02%
0.01
100.71%
-0.32
2,589.64%
capex to revenue
-0.18
-
-0.14
23.45%
-0.26
88.83%
-0.04
84.70%
-0.13
234.58%
-0.04
68.19%
-0.04
6.59%
-0.05
38.21%
-0.03
49.30%
-0.00
91.75%
-0.01
182.70%
cash per share
0.00
-
0.18
3,621.02%
0.03
82.59%
0.01
83.97%
0.01
118.44%
0.00
64.33%
0.00
24.70%
0.00
41.55%
0.00
74.16%
0.00
61.95%
0.00
50.44%
days of inventory on hand
490.98
-
784.69
59.82%
650.61
17.09%
403.31
38.01%
343.71
14.78%
437.15
27.19%
523.97
19.86%
499.01
4.76%
562.21
12.67%
645.88
14.88%
589.60
8.71%
days payables outstanding
602.73
-
517.73
14.10%
556.82
7.55%
493.98
11.28%
227.10
54.03%
200.05
11.91%
627.00
213.42%
493.54
21.29%
616.93
25.00%
519.16
15.85%
296.64
42.86%
days sales outstanding
71.25
-
36.15
49.27%
34.09
5.69%
37.38
9.66%
29.10
22.15%
62.26
113.96%
68.48
9.99%
50.89
25.69%
33.04
35.08%
46.62
41.10%
53.79
15.37%
debt to assets
0.27
-
0.08
69.13%
0.16
85.01%
0.21
36.66%
0.22
2.97%
0.50
126.28%
0.54
8.14%
0.98
82.38%
0.93
5.37%
1.16
24.56%
1.47
27.40%
debt to equity
-0.17
-
0.11
163.87%
0.28
147.42%
-11.98
4,448.80%
3.91
132.62%
-0.67
117.26%
-0.43
35.79%
-0.49
12.64%
-0.36
25.78%
-0.34
6.71%
-0.44
29.97%
dividend yield
0.02
-
0.05
166.94%
earnings yield
-0.19
-
-0.22
15.49%
-0.22
0.84%
-0.44
97.70%
-0.16
64.11%
-0.78
394.07%
-0.26
66.41%
-0.34
31.86%
-0.18
47.73%
-0.14
21.11%
-0.03
80.53%
enterprise value
13.51M
-
16.81M
24.45%
9.34M
44.43%
4.02M
56.95%
9.48M
135.74%
2.20M
76.76%
3.82M
73.41%
3.53M
7.59%
3.68M
4.22%
3.81M
3.54%
3.92M
2.88%
enterprise value over ebitda
-7.09
-
-7.16
0.93%
-5.76
19.52%
-3.04
47.26%
-9.31
206.40%
-2.65
71.58%
-5.83
120.25%
-5.32
8.67%
-10.01
88.15%
-15.55
55.26%
-71.15
357.68%
ev to operating cash flow
-18.51
-
-6.23
66.36%
-8.00
28.56%
-8.09
1.14%
-17.98
122.10%
-8.46
52.92%
529.15
6,351.54%
-14.19
102.68%
172.22
1,313.41%
-17.56
110.20%
133.21
858.65%
ev to sales
12.40
-
13.45
8.43%
8.21
38.98%
2.77
66.26%
6.85
147.27%
1.46
78.68%
2.58
76.64%
3.09
19.90%
2.64
14.55%
3.12
17.93%
2.68
13.86%
free cash flow per share
-0.15
-
-0.28
91.19%
-0.13
51.77%
-0.05
62.85%
-0.04
22.79%
-0.01
61.24%
-0.00
85.79%
-0.01
459.13%
-0.00
95.18%
-0.01
1,107.66%
0.00
108.87%
free cash flow yield
-0.07
-
-0.16
118.96%
-0.16
0.20%
-0.15
5.50%
-0.08
48.52%
-0.18
141.08%
-0.02
91.56%
-0.12
671.60%
-0.01
95.08%
-0.08
1,215.00%
0.01
110.34%
graham net net
-0.81
-
0.12
114.72%
-0.03
123.42%
-0.11
300.57%
-0.05
52.83%
-0.07
25.27%
-0.09
29.76%
-0.10
20.82%
-0.10
1.20%
-0.11
8.22%
-0.12
9.94%
graham number
2.15
-
1.58
26.44%
0.68
57.21%
0.09
86.75%
0.09
0.05%
0.23
152.57%
0.21
5.25%
0.24
13.27%
0.18
26.14%
0.16
8.83%
0.07
57.15%
income quality
0.30
-
0.67
125.86%
0.56
15.94%
0.30
46.35%
0.36
18.73%
0.19
47.15%
-0.01
104.81%
0.30
3,435.29%
-0.05
116.22%
0.54
1,192.68%
-0.42
178.79%
intangibles to total assets
0.33
-
0.16
51.55%
0.29
83.90%
0.34
15.74%
0.24
30.44%
0.03
85.62%
0.02
37.17%
0.01
46.15%
0.09
695.13%
0.04
50.88%
0.16
249.49%
interest coverage
-11.93
-
-20.90
75.25%
-41.73
99.67%
-26.07
37.53%
-26.68
2.33%
-21.88
17.99%
-10.56
51.74%
-9.27
12.19%
-4.96
46.45%
-3.32
33.06%
-0.81
75.58%
interest debt per share
0.12
-
0.04
63.79%
0.03
23.89%
0.03
1.84%
0.02
41.41%
0.03
34.00%
0.03
2.07%
0.04
46.30%
0.03
19.44%
0.03
6.21%
0.04
26.36%
inventory turnover
0.74
-
0.47
37.43%
0.56
20.61%
0.91
61.32%
1.06
17.34%
0.83
21.38%
0.70
16.57%
0.73
5.00%
0.65
11.24%
0.57
12.95%
0.62
9.54%
invested capital
-0.17
-
0.11
163.87%
0.28
147.42%
-11.98
4,448.80%
3.91
132.62%
-0.67
117.26%
-0.43
35.79%
-0.49
12.64%
-0.36
25.78%
-0.34
6.71%
-0.44
29.97%
market cap
12.96M
-
18.38M
41.81%
9.38M
49.00%
3.76M
59.87%
9.37M
149.05%
1.77M
81.10%
3.31M
86.68%
2.61M
21.06%
2.90M
11.24%
2.85M
1.71%
2.52M
11.80%
net current asset value
-4.77M
-
1.64M
134.46%
-18.32K
101.11%
-974.60K
5,221.03%
-759.51K
22.07%
-1.18M
55.75%
-1.79M
51.31%
-2.50M
39.89%
-2.84M
13.55%
-3.28M
15.48%
-3.73M
13.72%
net debt to ebitda
-0.29
-
0.67
332.82%
0.02
97.07%
-0.20
1,104.05%
-0.11
43.92%
-0.52
371.35%
-0.78
51.20%
-1.39
76.86%
-2.11
52.24%
-3.90
84.72%
-25.47
552.46%
net income per share
-0.39
-
-0.39
0.84%
-0.19
51.27%
-0.15
22.29%
-0.08
46.16%
-0.06
20.56%
-0.04
43.47%
-0.03
4.45%
-0.02
48.78%
-0.01
27.55%
-0.00
83.30%
operating cash flow per share
-0.12
-
-0.26
127.76%
-0.11
59.04%
-0.04
58.31%
-0.03
36.07%
-0.01
58.02%
0.00
102.50%
-0.01
3,262.65%
0.00
107.57%
-0.01
1,048.93%
0.00
113.19%
payables turnover
0.61
-
0.70
16.42%
0.66
7.02%
0.74
12.72%
1.61
117.52%
1.82
13.52%
0.58
68.09%
0.74
27.04%
0.59
20.00%
0.70
18.83%
1.23
75.01%
receivables turnover
5.12
-
10.10
97.13%
10.71
6.04%
9.76
8.81%
12.54
28.46%
5.86
53.26%
5.33
9.08%
7.17
34.57%
11.05
54.03%
7.83
29.13%
6.79
13.32%
research and ddevelopement to revenue
0.05
-
0.06
12.66%
0.06
13.62%
0.00
94.81%
0.00
33.27%
0.01
-
0.02
-
return on tangible assets
-1.74
-
-1.26
27.52%
-1.46
15.35%
-1.69
15.61%
-1.33
20.80%
-1.37
2.51%
-0.81
40.84%
-0.92
14.07%
-0.62
33.28%
-0.49
19.80%
-0.08
83.14%
revenue per share
0.17
-
0.12
29.33%
0.11
13.71%
0.13
24.97%
0.08
42.58%
0.07
7.30%
0.06
11.50%
0.04
29.25%
0.05
7.45%
0.04
17.96%
0.04
16.15%
roe
0.75
-
-1.40
287.94%
-1.82
29.67%
62.50
3,538.11%
-18.14
129.02%
1.79
109.89%
0.64
64.41%
0.45
28.84%
0.22
51.90%
0.14
36.85%
0.02
84.82%
roic
0.83
-
-0.88
205.38%
-1.39
58.64%
-5.68
307.74%
-3.40
40.14%
5.27
254.81%
1.07
79.77%
0.91
14.64%
0.39
57.60%
0.16
57.89%
-0.02
114.67%
sales general and administrative to revenue
2.58
-
2.71
4.95%
2.23
17.89%
1.79
19.66%
shareholders equity per share
-0.52
-
0.28
153.66%
0.11
62.42%
-0.00
102.26%
0.00
285.54%
-0.04
903.03%
-0.06
58.82%
-0.08
34.28%
-0.08
6.50%
-0.09
14.72%
-0.10
9.97%
stock based compensation to revenue
0.41
-
0.30
27.14%
0.24
19.98%
0.33
37.66%
0.24
27.12%
0.41
71.38%
0.36
12.90%
0.46
26.12%
0.24
46.22%
0.15
38.02%
0.01
95.43%
tangible asset value
-4.01M
-
2.28M
156.83%
551.88K
75.80%
-531.12K
196.24%
-261.17K
50.83%
-804.32K
207.97%
-1.38M
71.30%
-1.99M
44.63%
-2.48M
24.50%
-2.98M
20.10%
-3.48M
16.84%
tangible book value per share
-0.63
-
0.22
134.99%
0.05
77.07%
-0.05
194.27%
-0.01
70.38%
-0.04
161.97%
-0.06
54.43%
-0.08
32.76%
-0.08
9.68%
-0.09
12.22%
-0.11
13.63%
working capital
-4.77M
-
1.64M
134.46%
-18.32K
101.11%
-974.60K
5,221.03%
-759.51K
22.07%
-1.18M
55.75%
-1.79M
51.31%
-2.28M
27.20%
-2.66M
16.94%
-3.14M
17.82%
-3.49M
11.26%

All numbers in (except ratios and percentages)